Innovative Biotechnology

At ARGO THERAPEUTICS, we focus on pioneering interdisciplinary research to deliver First-in-Class therapies to address the unmet needs  of neurodegenerative diseases

We harness molecular pharmacology, state-of-the-art biophysics and AI-driven drug design to decode protein misfolding and neuronal signaling, so as  to explore new frontiers in Brain-targetted  biotechnology, targeting simultaneously multiple pathogenic pathways for neurodegenerative diseases.

Our pre-IND lead programs target ALS, Parkinson’s, and related neurodegenerative conditions using novel compounds that modulate protein function and neurovascular health

Our discovery engine integrates traditional  structure-enabled drug design and biomarker-guided development with targeting intrinsically disordered proteins, building a unique platform that is scalable across neurodegeneration.